Heron Therapeutics, Inc.
- HRTX
- NASDAQ
- Biotechnology
- Extended-Release Drug Delivery
$0.36
Today −0.22%Quote Oct 19, 2026, 02:34 PM UTC
+14.35%over the last month
Max drawdown −14.5%From 1-month high −13.1%3 months −24.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$68.4M
Quote Oct 19
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$6.67
+1751.7% from here
Floor
$0.35
1.4% below price
Where the price sits
19 analysts
Analyst range, low to high
$5.00$9.00
- Price $0.36
- Resistance $0.38
- Consensus $6.67
The price is just above its floor. Analysts' average target sits about 1752% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HRTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $37.7M
- C I N V A N T I$21.8M57.9%
- Z Y N R E L E F$11.1M29.4%
- S U S T O L$540,0001.4%
- Other / not reported$4.3M11.4%
Industry
Biotechnology
Employees
128